Table 2.
Lipid profiles and blood pressure (BP) by group at baseline and 12 weeks
| Baseline |
12 weeks |
p value | |||
|---|---|---|---|---|---|
| Placebo | Intervention | Placebo | Intervention | ||
| Total cholesterol (mg/dL) | 177.30 (32.48) | 182.48 (24.07) | 173.30 (37.95) | 174.60 (29.16) | 0.60 |
| Triglyceride (mg/dL) | 144.87 (83.24) | 128.12 (58.01) | 150.87 (78.74) | 145.92 (82.54) | 0.62 |
| HDL (mg/dL) | 51.30 (12.69) | 53.31 (13.54) | 49.82 (12.11) | 52.41 (12.58) | 0.84 |
| LDL (mg/dL) | 104.52 (36.09) | 108.64 (21.80) | 100.74 (32.05) | 105.04 (28.13) | 0.98 |
| Diastolic BP (mm/Hg) | 73.43 (8.72) | 77.60 (6.87) | 70.13 (8.31) | 73.36 (10.31) | 0.91 |
| Systolic BP (mm/Hg) | 132.30 (15.69) | 128.16 (10.55) | 124.61 (12.76) | 127.00 (16.25) | 0.10 |
Data are presented as the mean (SD)